Zhendong W. Chen
No.678 Furong Road
Hefei, China
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Matching-adjusted indirect comparison of fruquintinib versus ramucirumab in advanced gastric or gastroesophageal junction adenocarcinoma.
Journal: Journal of comparative effectiveness research
Published: August 12, 2026
Evidence of Higgs Boson Inclusive Production at High Transverse Momentum Decaying to a Pair of b-Quarks with the ATLAS Detector.
Journal: Physical review letters
Published: March 24, 2026
Combination of Measurements of CP Properties of Higgs Boson Interactions with Vector Bosons Using Proton-Proton Collisions at sqrt[s]=13 TeV with the ATLAS Detector.
Journal: Physical review letters
Published: March 24, 2026
Surufatinib plus toripalimab for patients with advanced solid tumors and disease progression after prior immunotherapy: an open-label multi-cohort phase 2 trial.
Journal: Cancer immunology, immunotherapy : CII
Published: February 10, 2026
Serplulimab Plus Chemotherapy, with or without HLX04, versus Chemotherapy as First-Line Treatment for Nonsquamous NSCLC: Final Survival Analysis of the Phase III ASTRUM-002 Study.
Journal: Cancer communications (London, England)
Published: January 08, 2026
Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.
Journal: Physical review letters
Published: July 08, 2025
Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors.
Journal: Drug design, development and therapy
Published: June 12, 2025
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study.
Journal: The Lancet. Oncology
Published: May 30, 2025
Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study.
Journal: European journal of medical research
Published: May 06, 2025
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: April 24, 2025
Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.
Journal: Physical review letters
Published: April 01, 2025
Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13 TeV with the ATLAS Detector.
Journal: Physical review letters
Published: March 17, 2025
Last Updated: 09/26/2026